Tag: Vaccines
38.6 Percent of 9- to 17-Year-Olds Have Received at Least One HPV Vaccine Dose
Likelihood of receiving HPV vaccine dose higher for children with private health insurance and for those with disability
COVID-19 mRNA Vaccines Safe During Pregnancy
In a large study, there were lower odds of neonatal mortality associated with vaccination
Updated COVID-19 Vaccine Has Effectiveness of 54 Percent
Vaccine effectiveness 49 percent at 60 to 119 days after vaccination among tests exhibiting spike gene target failure
Maternal COVID-19 Vaccination May Reduce Neonatal Respiratory Distress
The odds of neonatal respiratory distress were higher for unvaccinated mothers versus those vaccinated before infection
COVID-19 Vaccination in Pregnancy Safe for Infant Neurodevelopment
No difference seen for abnormal Ages and Stages Questionnaire screens for offspring at 12 or 18 months of age
COVID-19 Vaccine Uptake More Likely in Pregnancy if Receiving Other Vaccines
COVID-19 vaccine acceptance twice as high if Tdap or influenza vaccinations also received
COVID-19 Vaccine Uptake Lagging in Patients With Sickle Cell Disease
In Michigan, those with sickle cell disease have half the coverage rate of people without sickle cell disease
Cancer Vaccine Safe, Induces T-Cell Responses for KRAS-Mutated Tumors
Lymph node-targeting Amphiphile vaccine is safe; correlation seen for efficacy with T-cell response
Updated Immunization Schedule Presented for Adults for 2024
Changes include recommendation for all adults to receive dose of new COVID-19 vaccine and RSV vaccination
Bivalent COVID-19 Shot Effective for Preventing Thromboembolic Events
Findings seen for adults aged 65 years and older and for those aged 18 years and older with end-stage renal disease